Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
about
Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels.Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort studyEpidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006-2011)Epidemiology of severe sepsisGram-positive and gram-negative bacterial toxins in sepsis: a brief reviewSystemic Steroids in Severe Sepsis and Septic ShockInhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticlesVasopressors for hypotensive shockInterleukin-6 for diagnosis of sepsis in critically ill adult patientsUlinastatin and thymosin as immune modulators for the treatment of sepsisHuman recombinant activated protein C for severe sepsisConservative versus liberal fluid therapy for initial severe sepsis and septic shockHigh-volume haemofiltration for sepsisHuman recombinant protein C for severe sepsis and septic shock in adult and paediatric patientsUlinastatin and thymosin as immune modulators for the treatment of sepsisVasopressors for hypotensive shockHuman recombinant activated protein C for severe sepsisPerioperative prebiotics, probiotics or synbiotics for elective abdominal surgery in adultsHigh-volume haemofiltration for sepsisAntithrombin III for critically ill patientsHuman recombinant activated protein C for severe sepsisAntithrombin III for critically ill patientsDynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shockDrotrecogin alfa (activated): the first FDA-approved treatment for severe sepsisCorticosteroids for severe sepsis and septic shock: a systematic review and meta-analysisPre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis"Merinoff symposium 2010: sepsis"-speaking with one voiceEpidemiologic study of in-hospital cardiopulmonary resuscitation in the elderlyAssociation between acute care and critical illness hospitalization and cognitive function in older adultsAssessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortalityMethylene blue for distributive shock: a potential new use of an old antidoteLong-term cognitive impairment and functional disability among survivors of severe sepsisLactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trialThe effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysisSurviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008Trends in vital signs and routine biomarkers in patients with sepsis during resuscitation in the emergency department: a prospective observational pilot studyVascular endothelial growth factor is an important determinant of sepsis morbidity and mortalitySafety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsisThe Surviving Sepsis Campaign: raising awareness to reduce mortality
P2860
Q21092899-3A7C91DC-3DB1-4FE1-AEDA-8821012A41BFQ21261826-4AB83977-7074-4A30-8C72-B9C8A0B512B5Q21999482-6B8E6ACC-93C4-4EF2-80EC-1DAC37572BFFQ22305425-8C8541E6-2BF0-4421-8435-4ED049E1D993Q22305427-7D042195-F007-43FF-8B8C-92AE22101E95Q22306309-5B8DB5AC-2778-4AAB-A331-126080ABEF87Q23923217-364B476C-ECD7-416F-9BD2-F5DF6EE8AA35Q24186138-01C36E8D-CFB7-48FF-8A49-341929DA7FD3Q24186689-5A65B2F1-AA47-41A0-A7BA-024F300BC359Q24193380-16FFD1B7-63DD-43A1-AFBD-F223B753B8C6Q24201123-F01F4518-7DFE-46C4-90A4-36F652161B4AQ24201685-B6DEC0E3-CCAF-41AC-8FC1-CD19C962AE1BQ24201745-9D2C908B-F40B-45A2-A37B-125016A7186DQ24202128-3F36243E-6977-4E55-8790-9ABF438B76CCQ24202365-76064983-28EE-4A80-9965-1CFC689B44ABQ24234415-736DC86C-C5E4-4C93-A736-5A3B2CC13F1DQ24235181-9F1D077B-6BB0-4E4A-B430-D40B7DC7B462Q24236166-E3224E63-F073-4609-B815-C5112D706F5AQ24241649-F7FFE34A-D343-4DBC-B446-886A01AB9433Q24242053-9FA46B23-AB23-47DE-A296-EE11F959F2C9Q24242859-1CB63490-E6C8-45DC-8DCE-7687FAB62E1EQ24246826-C927B84E-A1D7-436A-9FBB-DF0D1F356B6FQ24303939-EB8A8748-9036-4BBF-8939-74C8F82EFE9FQ24315988-EE52E4B0-D46C-4DB2-A6F0-E7AA3DA9C5B8Q24536981-27E933BD-9E8B-4894-817A-91A62BBA24DDQ24562848-A4971AE6-1A0B-4A11-8D1A-94EFF17650CFQ24568212-7046CA26-4EB2-45E4-97E5-3C4FE82318D4Q24595002-5DF7416E-DE43-4FC1-8AF4-789E6482EE79Q24595413-0A7405AC-6D6A-4CFB-A2BE-E2D6C7BC5BA6Q24602638-D197BF13-EF9B-4403-BD55-D434BAFD8B74Q24621520-061DE421-7D9E-460D-948F-7662596D6420Q24624791-7832F162-D566-4DA3-B9CD-435BB0B8C84CQ24628579-7DB96195-41E2-4A02-9514-A994F6C72EF7Q24633766-59504CC3-896B-40DF-B95B-41E165E3E9B2Q24642798-7FADD0F9-8D34-4AA9-972B-2B484C65A582Q24644984-F117706D-C1AC-4769-9D8B-4C87C59DE908Q24658662-FAAFD831-AD2C-4262-91F1-2D25B0E5766FQ24676668-40696C2E-95E0-4CBD-B36C-9584AC2D40E3Q24794551-C7399861-E6E7-4746-B9AF-1FC9EBC79194Q24794875-BBE7F3FF-B7F9-439B-B28C-88BAEB7155E2
P2860
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Epidemiology of severe sepsis ...... , and associated costs of care
@ast
Epidemiology of severe sepsis ...... , and associated costs of care
@en
Epidemiology of severe sepsis ...... , and associated costs of care
@nl
type
label
Epidemiology of severe sepsis ...... , and associated costs of care
@ast
Epidemiology of severe sepsis ...... , and associated costs of care
@en
Epidemiology of severe sepsis ...... , and associated costs of care
@nl
prefLabel
Epidemiology of severe sepsis ...... , and associated costs of care
@ast
Epidemiology of severe sepsis ...... , and associated costs of care
@en
Epidemiology of severe sepsis ...... , and associated costs of care
@nl
P2093
P3181
P1476
Epidemiology of severe sepsis ...... , and associated costs of care
@en
P2093
G Clermont
J Carcillo
J Lidicker
M R Pinsky
W T Linde-Zwirble
P304
P3181
P356
10.1097/00003246-200107000-00002
P407
P577
2001-07-01T00:00:00Z